Edwards Lifesciences Form 144: 3,058-share sale, $252,423 value

Edwards Lifesciences (EW) filed a Form 144 for a proposed sale of 3,058 shares of common stock through Charles Schwab & Co., Inc. on 11/10/2025.

Accepted by SEC EDGAR 11/10/2025 - 04:08 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Edwards Lifesciences (EW) filed a Form 144 for a proposed sale of 3,058 shares of common stock through Charles Schwab & Co., Inc. on 11/10/2025. The aggregate market value listed is $252,423, with sales on the NYSE. The shares were acquired the same day via an employee stock option exercise with broker payment for a cashless exercise. Shares outstanding were 580,300,000; this is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Edwards Lifesciences (EW) file?

A Form 144 notice for a proposed sale of 3,058 common shares.

What is the aggregate market value of the shares to be sold?

The filing lists an aggregate market value of $252,423.

When is the approximate sale date for EW shares?

The filing states an approximate sale date of 11/10/2025.

How were the shares acquired before the sale?

Via an employee stock option exercise with broker payment for cashless exercise on 11/10/2025.

Which broker and exchange are listed?

Broker: Charles Schwab & Co., Inc.; Exchange: NYSE.

How many Edwards Lifesciences shares are outstanding?

The filing lists 580,300,000 shares outstanding (baseline figure).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002004380
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Edwards Lifesciences Corp
SEC File Number	001-15525
Address of Issuer	ONE EDWARDS WAY IRVINE CALIFORNIA 92614
Phone	9492502500
Name of Person for Whose Account the Securities are To Be Sold	Lippis Daniel J.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3058	252423.00	580300000	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/2025	Employee Stock Option Exercise - see remarks	EDWARDS LIFESCIENCES CORPORATION			3058	11/10/2025	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The options on this filing may be sold over various dates.
Date of Notice	11/10/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/30/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daniel J. Lippis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)